Novel disubstituted 4-hydroxyphenylthio anilides

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

564162, 514826, 514825, 514886, 514887, 514863, C07C32341, A61K 31165

Patent

active

050718762

ABSTRACT:
The compounds of this invention are anilides represented by the formula: ##STR1## wherein: R.sub.1 and R.sub.2 are the same or different members of the group consisting of halo, phenyl, substituted phenyl and a ##STR2## group wherein n, m and p are independently an integer of from 1 to 8 provided that n+m+p is equal to or less than 10; X is thio, sulfinyl or sulfonyl; Alk is straight or branched chain lower alkylene; R.sub.3 is hydrogen or lower alkyl; and R.sub.4 is phenyl or substituted phenyl. The compounds of the present invention are useful in the treatment of inflammation, allergy and hypersensitivity reactions and other disorders of the immune system.

REFERENCES:
patent: 3039863 (1962-06-01), Fancher et al.
patent: 3392194 (1968-07-01), Waring
patent: 3652646 (1972-03-01), Leigh et al.
patent: 4029812 (1977-06-01), Wagner et al.
patent: 4153803 (1979-05-01), Thiel et al.
patent: 4528286 (1985-07-01), Moller
patent: 4835189 (1989-05-01), Mueller et al.
patent: 4954514 (1990-09-01), Kita et al.
Samuelsson, "Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation", Science, vol. 220, 1983, pp. 568-575.
Bach, "Inhibitors of Leukotriene Synthesis and Action", The Leukotrienes, Chemistry and Biology, Academic Press, pp. 163-194 (1984).
Lee et al., "Human Biology and Immunoreactivity of Leukotrienes", Advances in Inflammation Research, vol. 6, pp. 219-225, Raven Press (1984).
Editorial, "Leukotrienes and Other Lipoxygenase Products in the Pathogenesis and Therapy of Psoriasis and Dermatoses", Arch. Dermatol., vol. 119, pp. 541-547 (Jul. 1983).
Lewis et al., "A Review of Recent Contributions on Biologically Active Products of Arachidonate Conversion", Int. J. Immunopharma, vol. 4, No. 2, pp. 85-90, (1982).
Bach, "Prospects for the Inhibition of Leukotriene Synthesis", Biochemical Pharmacology, vol. 33, No. 4, pp. 515-521 (1984).
Becker, "Chemotactic Factors of Inflammation", pp. 223-225, (Elsevier Science Publishers B.V. Amsterdam, 1983).
Sharon et al., "Enhanced Synthesis of Leukotriene B.sub.4 by Colonic Mucosa in Inflammatory Bowel Disease", Gastroenterology, vol. 86, pp. 453-460 (1984).
Musch et al., "Stimulation of Colonic Secretion by Lipoxygenase Metabolites of Arachidonic Acid", Science, vol. 217, p. 1255 (1982).
Harvey et al., "The Preferential Inhibition of 5-Lipoxygenase Product Formation by Benoxaprofen", J. Pharm. Pharmacol., vol. 35, pp. 44-45, (1983).
Chem. Abst. 90:151802x, vol. 90 (1979) (Tsuda).
Khim. Tekhnol. 20(4), pp. 568-574 (1977), translation.
Pestic. Biochem. Physiol., 12(1), 23-30 (1979).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Novel disubstituted 4-hydroxyphenylthio anilides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel disubstituted 4-hydroxyphenylthio anilides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel disubstituted 4-hydroxyphenylthio anilides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1040971

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.